Spontaneous Tumor Lysis Syndrome in a Patient with a Dedifferentiated Endometrial Adenocarcinoma

Table 2

Review of spontaneous TLS in patients with solid tumors.

Tumor	Age	Sex	UA	K	Ca	P	Ref
			(mg/dL)	(mEq/L)	(mg/dL)	(mg/dL)
Adenocarcinoma unknown origin	50	M	37	6.5	8.3	9.2	[3]
Adenocarcinoma unknown origin	59	F	26.5	ND	6.5	8.8	[4]
Adenocarcinoma unknown origin	71	F	10.3	5.78	9.6	6	[5]
Breast lobular carcinoma	62	F	10.1	ND	10.1	6	[6]
Cholangiocarcinoma	66	M	9.9	4.8	8.7	3.8	[7]
Colon cancer	82	F	20.4	ND	5.7	5.5	[8]
Gastric adenocarcinoma	36	M	16.9	5.6	7	6.9	[9]
Gastric adenocarcinoma	51	M	27.9	5.3	8.9	15.2	[10]
Germ cell tumor	13	F	28	5.6	7.2	7.3	[11]
Germ cell tumor	22	M	18	7.2	9.6	7.2	[12]
Germ cell tumor	52	M	21.8	7.9	5	7.1	[13]
Germ cell tumor	24	M	24	8.5	7.6	10	[13]
Hepatocellular carcinoma	72	M	20.1	4.5	7.2	5.4	[8]
Hepatocellular carcinoma	76	M	16.3	6.9	7.7	8.9	[14]
Hepatocellular carcinoma	70	M	22.9	6	11	6.9	[15]
Lung adenocarcinoma	72	M	12.6	7	8.2	8.3	[16]
Lung SCC	74	M	15.4	5.2	ND	4.7	[17]
Lung small cell lung cancer	53	M	8.3	6.1	ND	5.3	[18]
Maxillary SCC	53	M	20.9	7.6	6.2	11.8	[19]
Melanoma	69	M	24.6	6.3	8.4	3.8	[20]
Merkel cell cancer	87	F	13.9	5.6	7.3	7.2	[21]
Ovarian carcinoma	71	F	10.3	5.78	9.7	5.8	[22]
Pancreatic adenocarcinoma	56	F	14.3	7.5	4	6.3	[23]
Pheochromocytoma	80	M	16.5	6.6	8.4	5.8	[8]
Prostate cancer	72	M	28.1	4.9	8	8.3	[24]
Prostate cancer	56	M	16.4	5.7	10	11.7	[25]
Renal cell carcinoma	56	M	24.6	5	9.4	10.5	[26]
Sarcoma	49	F	14.3	5.1	7.7	6.9	[27]